1 / 25

By Dr. Nadia AL.Assady F.I.B.O.G C.A.B.O.G

Intersex. By Dr. Nadia AL.Assady F.I.B.O.G C.A.B.O.G. Introduction. there has been a recent change in the terminology used to refer to these conditions. older terms are confusing to both the clinician & patients & can be hurtful which include : a-46 XY DSD b-46 XX DSD

phu
Download Presentation

By Dr. Nadia AL.Assady F.I.B.O.G C.A.B.O.G

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Intersex By Dr. Nadia AL.Assady F.I.B.O.G C.A.B.O.G

  2. Introduction

  3. there has been a recent change in the terminology used to refer to these conditions. older terms are confusing to both the clinician & patients & can be hurtful which include : a-46 XY DSD b-46 XX DSD c- ovotesticular DSD

  4. There are 3 factors that determine sexual development • 1-the effect of sex chromosomes on the differentiation of the gonads. • 2-the proper functioning of the differentiated testis • 3-the response of the end organ to this testicular function

  5. The testis carry out their intrauterine function by producing 2 substances: • a. Testosterone. • b. mullerian inhibitory factors. • The testosterone give rise to the development of wolffian duct • MIF it is glycoprotein produced by sertoli cells which inhibit the development of mullerian duct

  6. Its have unilateral action &each testis appear to produce the MIF which result in regression mullerian structures on its own sides . • The sensitivity of mullerian structures to MIF is present only during the first 8 wk of gestation.

  7. Clinical presentation: • The child with ambiguous genitalia may present in a numbers of ways: • 1 .a masculinized female due to CAH or androgen stimulation from another sources. • 2. an under masculinized male . • 3.true hermaphrodite.

  8. Congenital adrenal hyperplasia • Its an autosomal recessive disorders ,resulting in enzyme deficiency related to the biosynthesis of cortisol & aldosterone . the commonest enzyme defect is 21-hydroxylase ,its account for(90%) of cases this result in increase in progesterone& 17 – hydroxyprogesterone which than converted to androsterodione& then to testosterone.

  9. CLF: • The incidence rate between(1/5000-1/15000) those females born with enlargement of clitoris &excessive fusion of labia majora resemble the scrotum which obscure the vagina & urethra . • The uterus ,fallopian tubes & vagina are always present .in some infants dangerous salt losing syndrome may arise because of associated aldesterone deficiency & the child may die from wasting & vomiting within few wks of life if the case not diagnose.

  10. Management • Counseling the parents &reassure them that the child is healthy but there is developmental error of genitalia & if examination fail to identify palpable gonads so the child most likely female.

  11. Investigation: • 1. karyotyping performed on cord blood. • 2.measurement 17 hydroxy progesterone in blood which increased. • 3.electrolytes levels to exclude salt losing syndrome. (here Na & CL may reduce &K increase). • 4.pelvic U/S to see the uterus & vagina. • Treatment • Medical by cortisone • Surgical by cliteroplasty & division of fused labia.

  12. XY FEMALE • This condition result from either: • A .abnormal androgen production. This is due to • 1-anatomical testicular failure: • Failure of normal testis development may be due to the chromosomal mosaicim & here the condition called pure gonadaldysgensis

  13. CLF/ most patient have mild masculinization or none at all, the uterus, tubes & vagina are present • Management • 1. reconstruction of external genitalia • 2.removal of streak gonads because the potential risk of malignancy • 3.HRT are giving around the age of puberty to induce secondary sexual characters & menstruation

  14. 2-enzymatic testicular failure: • There is biosynthetic steps defect in the formation of testosterone • CLF/ there is variable degree of ambiguous genitalia the uterus, tubes & vagina are absent because MIF production is normal. • Management • 1-decision of sex of rearing usually female • 2-surgical reconstruction

  15. B . insensitivity to androgen production. this is due • 1.5 –alpha reductase deficiency : • Normal masculinization of the external genitalia require the conversion of testosterone to dihydrotestosterone by 5-alpha reductase.

  16. CLF/In this case the male infant have poor masculinization of external genitalia but the uterus ,tubes & vagina are absent • .most child are place in femle role. At puberty the testis produce high amount of testosterone & there is greater virilization to extent the patient wish to change the gender from female to male

  17. Management 1-decision of sex of rearing 2-surgical reconstruction • 2.androgen insensitivity syndrome • this is due to complete absence of the gene for androgen receptor & called complete AIS. • If there is mutation or defect of gene so there is partial receptor binding & called partial AIS.

  18. CLF/ • most patient present for first time after puberty with primary amenorrhea despite normal breast development • on examination there is scanty or absent axillary &pubic hair ,normal vulva but short blind vagina no palpable cervix

  19. management • 1.karyotyping reveal 46 XY male pattern • 2.endocrine testing: • a-testosterone level within normal male range. • b-estrogen level are within the range where normal male & female value overlap • 3.laproscopy reveal absent uterus& testis found in the abdomen ,inguinal canal & labia.

  20. Treatment • a. counseling the patient that they are entirely female despite their karyotypes. • b. discussion with the patient the need for removal of their gonads because the risk of malignancy. • c.HRT with estrogen only because have no uterus. • d. if the vagina not functional so graduated dilatation using frank procedure. • True hermaphrodite

  21. Thank you

More Related